Neumirna Therapeutics has raised €20m to develop microRNA therapies for epilepsy and other neurological conditions.

Epilepsy is now considered a network disease that affects the brain across multiple levels of spatial and temporal scales. The paradigm shift from an epileptic focus—a discrete cortical area from ...

Jackson Labs’ continuous video-based monitoring of mice with AI-enabled analysis reveals fresh insights weeks earlier than ...

Computational models of epilepsy have advanced rapidly ... It is not sufficient for a theoretical model simply to reproduce observed physiology—it must be able to inspire novel predictions and ...

Traditionally, treatments focus on ion channels and receptors in neurons; however, recent research highlights the role of astrocytes and microglia in epilepsy's pathophysiology. Non-selective macro ...

Roth, MD, Ph.D., the Michael Hooker Distinguished Professor of Pharmacology, and Grégory Scherrer, PharmD, Ph.D., associate professor of cell biology and physiology and the UNC Neuroscience ...

Background Within the general epilepsy population, the incidence of Sudden Unexpected Death in Epilepsy (SUDEP) ranges from approximately 0.35 to 2.3 per 1,000 individuals per year. Objective We aimed ...

Upon consumption by humans, they develop into a new intestinal tapeworm. Affecting the human brain, neurocysticercosis is responsible for a third of epilepsy cases in endemic tropical and subtropical ...

By using it at home, patients can unlock new insights into sleep physiology. Dreem 3S — the ... scientific posters this week at the American Epilepsy Society (AES) Annual Meeting.

Epilepsy is associated with poor brain health, with a consistent deleterious effect seen on cognitive and motor function and ...

A single amino acid change in a neuronal ion channel called KCNQ2 blocks ion flow, prevents protein localization on axons, and results in severe epilepsy and slowed neurological development.